ArticleJournal of imaging2025
MedSAM/MedSAM2 Feature Fusion: Enhancing nnUNet for 2D TOF-MRA Brain Vessel Segmentation.
Article in Journal of imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Automated Craniofacial Artery Segmentation with Vessel Enhancement-Guided Deep Learning.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Accurate segmentation of brain vessels is critical for diagnosing cerebral stroke, yet existing AI-based methods struggle with challenges such as small vessel segmentation and class imbalance. To address this, our study proposes a novel 2D segmentation method based on the nnUNet framework, enhanced with MedSAM/MedSAM2 features, for arterial vessel segmentation in time-of-flight magnetic resonance angiography (TOF-MRA) brain slices. The approach first constructs a baseline segmentation network using nnUNet, then incorporates MedSAM/MedSAM2's feature extraction module to enhance feature representation. Additionally, focal loss is introduced to address class imbalance. Experimental results on the CAS2023 dataset demonstrate that the MedSAM2-enhanced model achieves a 0.72% relative improvement in Dice coefficient and reduces HD95 (mm) and ASD (mm) from 48.20 mm to 46.30 mm and from 5.33 mm to 4.97 mm, respectively, compared to the baseline nnUNet, showing significant enhancements in boundary localization and segmentation accuracy. This approach addresses the critical challenge of small vessel segmentation in TOF-MRA, with the potential to improve cerebrovascular disease diagnosis in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.